New Lyme Disease Guidelines for Erythema Migrans Lesions Miss the Mark.

No abstract is available for this paper.

• Publication year

  2022

• Venue

  American Journal of Medicine

• Publication date

  2022-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.amjmed.2021.08.017PMID 35148821
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence-Based, Patient-Centered Treatment of Erythema Migrans in the United States

  2021cited by this paper
• Guidelines for Lyme Disease are Updated.

  2021cited by this paper
• The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome

  2017cited by this paper
• Borrelia burgdorferi sensu stricto and Borrelia afzelii: Population structure and differential pathogenicity.

  2015cited by this paper
• Treatment of erythema migrans with doxycycline for 10 days versus 15 days.

  2012cited by this paper
• A Twist on Lyme: the Challenge of Diagnosing European Lyme Neuroborreliosis

  2010cited by this paper
• Duration of Antibiotic Therapy for Early Lyme Disease

  2003cited by this paper
• Treatment of early Lyme disease.

  1992cited by this paper

• No citing papers are available for this paper.